Skip to content

Exome Sequencing and Molecular Profiling in Patients with Hidradenitis Suppurativa (HS)

Exome Sequencing and Molecular Profiling in Patients with Hidradenitis Suppurativa (HS) - HSProGen

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57185
Enrollment
400
Registered
2024-09-19
Start date
2024-10-15
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne ectopica Hidradenitis Suppurativa

Interventions

None listed

Sponsors

The European Hidradenitis Supurativa Foundation (EHSF) e.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Male or female, age 18 years or older at the screening visit • Patients must have a diagnosis of HS (in compliance with Dessau criteria as modified in San Francisco) for at least one year (365 days) prior the screening visit • HS lesions must be present in at least two distinct classical anatomic areas (e.g., left and right axilla; or left axilla and left inguino-crural fold) • Willing and able to comply with clinic visits and study-related procedures • Provide informed consent signed by study patient or legally acceptable representative • Able to understand and complete study-related material

Exclusion criteria

Exclusion criteria: - Presence of skin comorbidities (e.g. inverse psoriasis, epidermal inclusion cyst) that may interfere with study assessments for HS - Severe concomitant illness(es) - Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frame
Whole-exome sequencing and/or array genotyping to identify single variants and/or gene-based burden tests significantly associated with HS status and severity.

Secondary

MeasureTime frame
Transcriptional profiling through bulk RNA sequencing.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)